Home > API & Intermediate > Inhibitors > Apixaban Manufacturers > Apixaban

Apixaban

CAS NO.： 503612-47-3

FOB Price： NEGOTIABLE Get Latest Price

Specification： 99.0%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 25KG/Fibre Drum

Product Detail

Properties

Apixaban

Introduction：Apixaban is a new oral factor Xa inhibitor jointly developed by Bristol Myers Squibb and Pfizer. Its trade name is elotal. It is a new oral anticoagulant. Apixaban prevents thrombin production and thrombosis by inhibiting an important coagulation factor Xa.

CAS：503612-47-3

Molecular formula：C25H25N5O4

Molecular weight：459.5

Structure：

Uses：Prevention of thrombin production and thrombosis

Properties

Apixaban (inn, trade name eliquis) is an anticoagulant used to prevent venous thromboembolism and atrial fibrillation stroke. It is a direct factor Xa inhibitor. Apixaban has been listed in Europe since May 2011. The drug was developed by a joint venture between Pfizer and Bristol Myers Squibb.

CAS No.

503612-47-3

Formula

C25H25N5O4

Molecular Mass

459.49700

Exact Mass

459.19100

PSA

110.76000

Logp

3.52990

IUPAC

1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide

Matter Classification

organic

Category

Density

1.42g/cm3

Boiling Point

770.468ºC

Flash Point

419.764ºC

Appearance

solid

Acidity and Basicity

alkalinity

HS Code

29339900

Send your message to this supplier

To：

Zhejiang Jingxin Pharmaceutical Co.,Ltd.

Not exactly what you want? One request, multiple quotations Get Quotations Now >>

Supplier's main products

b

Send Email

Apixaban